| scholarly article | Q13442814 |
| P2093 | author name string | James Crapo | |
| David A Lynch | |||
| Douglas Curran-Everett | |||
| Edwin K Silverman | |||
| Michael H Cho | |||
| Terri H Beaty | |||
| Ingo Ruczinski | |||
| Robert B Scharpf | |||
| Jacqueline B Hetmanski | |||
| Margaret M Parker | |||
| Ferdouse Begum | |||
| Shengchao Li | |||
| P2860 | cites work | The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. | Q53572756 |
| Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. | Q54433238 | ||
| Genome-wide association study of copy number variations associated with pulmonary function measures in Korea Associated Resource (KARE) cohorts | Q57226791 | ||
| DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease | Q57757087 | ||
| Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) | Q57955885 | ||
| Accurate airway wall estimation using phase congruency | Q62490747 | ||
| The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? | Q87196000 | ||
| Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 | ||
| Standardisation of the measurement of lung volumes | Q28269989 | ||
| Interpretative strategies for lung function tests | Q28279970 | ||
| Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene | Q28383674 | ||
| The Genotype-Tissue Expression (GTEx) project | Q28657968 | ||
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis | Q29416987 | ||
| STRING v9.1: protein-protein interaction networks, with increased coverage and integration | Q29614691 | ||
| LocusZoom: regional visualization of genome-wide association scan results | Q29614868 | ||
| PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data | Q29614933 | ||
| The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study | Q30504247 | ||
| A genome-wide study of de novo deletions identifies a candidate locus for non-syndromic isolated cleft lip/palate risk | Q31151570 | ||
| Dynamic lung hyperinflation and its clinical implication in COPD | Q33441638 | ||
| Genetic syndromes associated with overgrowth in childhood | Q33635229 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations | Q33986398 | ||
| Genetic epidemiology of COPD (COPDGene) study design | Q34074731 | ||
| Fast computation and applications of genome mappability | Q34140534 | ||
| The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial | Q34216188 | ||
| Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study | Q34308364 | ||
| Fast detection of de novo copy number variants from SNP arrays for case-parent trios | Q34509681 | ||
| High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping | Q35012994 | ||
| Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature | Q35477955 | ||
| A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. | Q35816887 | ||
| Interobserver variability in the determination of upper lobe-predominant emphysema | Q36734384 | ||
| Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. | Q36769613 | ||
| Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms | Q36959677 | ||
| Copy number variation of the beta-defensin genes in europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma | Q37431463 | ||
| Deaths: Leading Causes for 2011. | Q40682159 | ||
| Pulmonary hyperinflation a clinical overview | Q41289358 | ||
| PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1. | Q41562535 | ||
| A GC-wave correction algorithm that improves the analytical performance of aCGH. | Q44844596 | ||
| Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. | Q51647885 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 81-88 | |
| P577 | publication date | 2015-12-07 | |
| P1433 | published in | Genetic Epidemiology | Q5532864 |
| P1476 | title | Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort | |
| P478 | volume | 40 |
Search more.